The company says the observations are procedural in nature.
Aurobindo Pharma subsidiary’s plant in Andhra Pradesh issued five observations by U.S. FDA
Published 1 day ago
Source: thehindu.com
Categories
Industry
Related Articles from thehindu.com
10 minutes ago
Under-19 Asia Cup final: India looks to extend dominance against Pakistan
18 minutes ago
Careers in sports beyond the field: scope and future
21 minutes ago
Eggs safe for consumption; cancer risk claims unfounded: FSSAI
21 minutes ago
Nuclear Bill ‘bulldozed’ in Parliament to help PM Modi restore ‘SHANTI’ with ‘once good friend’: Congress
33 minutes ago
T.N. police warn public about new cyber scam involving USSD codes
35 minutes ago